An update on Thursday confirmed those details, and revealed that pharmaceuticals exported from the EU to the U.S. will see tariffs capped at 15%. That alleviated some concerns, as U.S. President Donald Trump had previously threatened to slap the sector with tariffs as high as 250%.

The European Union has escaped a potential 250% pharmaceutical tariff and instead has secured a maximum 15% levy with the U. S.